FindTrial
Sign In

A disgnostic test of using CMV-specific T cell responses to predict infection or reactivation of CMV in renal transplant recipients

A disgnostic test of using CMV-specific T cell responses to predict infection or reactivation of CMV in renal transplant recipients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17013567
Enrollment
Unknown
Registered
2017-11-27
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cytomegalovirus infection

Interventions

Gold Standard:Anti CMV-IgM, CMVDNA
Index test:CMV-specific T cell

Sponsors

Peking Union Medical College Hospita
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Patients planning to accept renal transplantation; 2. Age 18-74 years; 3. Blood CMV-IgM, CMVDNA were negative; 4. No clinical manifestation of CMV syndrome, such as fever, muscle pain, joint pain, anorexia, malaise and other symptoms; 5. No clinical manifestation of tissue invasive CMV disease, such as interstitial pneumonia, hepatitis, pancreatitis, gastroduodenitis, colitis, myocarditis and retinal.

Exclusion criteria

Exclusion criteria: 1. Acquired immunodeficiency syndrome; 2. Multiple organ transplantation; 3. Severe heart failure; 4. Tumor; 5. Kidney transplant between identical twins; 6. transplant renal insufficiency.

Design outcomes

Primary

MeasureTime frame
Cytomegalovirus specific T cell response;CMVDNA;SPE, SEN, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactXiaoqing Liu

Peking Union Medical College Hospital

liuxq@pumch.cn+86 13911761571; 010-69155087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026